AcroCyte to Participate in Cancer R&D 2026 in Houston
Events September 9, 2026

The 2026 International Conference on Cancer Research and Development (Cancer R&D 2026) will take place from November 2–4, 2026, in Houston, Texas. Organized by United Scientific Group, the three-day congress brings together researchers, clinicians, and industry professionals to advance basic, preclinical, and translational cancer research.

This year’s scientific program will explore key areas across cancer progression and prognosis, early cancer detection, precision oncology, computational biology and AI, therapeutic development, and organ-specific cancer research. The program also highlights emerging approaches in targeted therapy, cellular therapies, and novel cancer drug development.

We are pleased to announce AcroCyte Therapeutics’ participation in Cancer R&D 2026. During the conference, we will showcase our proprietary R³CE® (Rapid, Reproducible, Rare Cell 3D Expansion) platform and its potential to transform limited patient specimens into functional 3D cancer models for drug discovery, therapeutic evaluation, and translational research.

R³CE® is a scaffold-free 3D cell culture platform designed to rapidly expand rare cells from limited clinical specimens, including circulating tumor cells, needle biopsies, and frozen tissues. By enabling the generation of functional 3D models from precious patient-derived samples, R³CE® provides researchers with new opportunities to investigate tumor biology, conduct functional studies, and explore patient-relevant approaches to cancer research and drug development.

We invite researchers, clinicians, and industry professionals attending Cancer R&D 2026 to connect with the AcroCyte team and discover how R³CE® technology can help bridge patient-derived specimens and human-relevant cancer models, supporting the next generation of cancer research and therapeutic development.

Event Information

▸ Date｜November 2–4, 2026
▸ Venue｜Sheraton North Houston at George Bush Intercontinental, Texas
▸ Official Website｜Cancer R&D 2026 Official Website

Day 1 | November 2, 2026

Liquid Biopsy Session: Liquid Biopsy Technologies in Cancer Medicine

▸ Title｜Emerging Technologies in Liquid Biopsy
▸ Speaker｜Mark Pegram, MD, Stanford University School of Medicine, CA
▸ Date｜November 2, 2026
▸ Time｜11:25 AM – 11:45 AM

▸ Title｜A Novel Platform for the Ex Vivo Expansion of Circulating Tumor Cells
▸ Speaker｜Ying C. Chang, PhD, CEO and Co-Founder, AcroCyte Therapeutics Inc.
▸ Date｜November 2, 2026
▸ Time｜11:45 AM – 12:05 PM

▸ Title｜Panel Discussion
▸ Moderator｜Mark Pegram, MD, Standford University School of Medicine
▸ Panelists｜Ying C. Chang, PhD, AcroCyte Therapeutics Inc., Mark Pegram, MD, Standford University School of Medicine, Paraskevi Giannakakou, PhD, Weill Cornell Medicine 
▸ Date｜November 2, 2026
▸ Time｜12:05 PM – 12:25 PM

Day 2 | November 3, 2026

Plenary Session II

▸ Title｜Therapeutic Strategies Targeting HER2
▸ Speaker｜Mark Pegram, MD, Stanford University School of Medicine, CA
▸ Date｜November 3, 2026
▸ Time｜09:10 AM – 09:50 AM

▸ Title｜Functional Precision Oncology with Patient-Derived Organoids: Bridging Drug Discovery and Clinical Translation
▸ Speaker｜Ying C. Chang, PhD, CEO and Co-Founder, AcroCyte Therapeutics Inc.
▸ Date｜November 3, 2026
▸ Time｜09:50 AM – 10:30 AM
Back
Privacy Preference Center

1. Who We Are
At AcroCyte Therapeutics Inc. (“AcroCyte”, “we”, “our”), we are committed to maintaining the trust and confidence of all visitors to our website, www.acrocyte.com. We value your privacy and want you to be clear about how we handle your data. In particular, AcroCyte is not in the business of selling, renting, or trading email lists with other companies for marketing purposes. This Privacy Policy outlines when and why we collect personal information, how we use it, the limited conditions under which we may disclose it to others, and how we keep it secure.

2. Information We Collect & How We Use It
Contact Forms & Business Inquiries
When you contact us via the forms on our website (such as the "Contact Us" page), we collect the professional information you provide, including your name, email address, phone number, company name, job title, industry, area of interest, and the content of your inquiry.

  • Purpose: We use this data solely to communicate with you, verify your identity, answer your technical or business questions, and provide information about our products and services relevant to your request.
  • Marketing Communications: We will only send you newsletters, product updates, or promotional materials if you have explicitly opted in by checking the relevant box (e.g., "Yes, I'd like to receive updates about AcroCyte news and breakthroughs"). You may unsubscribe from these communications at any time by clicking the "unsubscribe" link in our emails.

Cookies
We use cookies to support essential website functionality and to provide a better user experience. You can choose to disable or delete cookies at any time through your internet browser settings; however, this may limit your ability to use certain features of our website.

3. Third-Party Services & Data Processors

Google Analytics
We use Google Analytics to collect standard internet log information and details of visitor behavior patterns. This helps us understand website traffic and improve performance. This information is processed in a way that does not identify anyone personally. We do not make, and do not allow Google to make, any attempt to find out the identities of those visiting our website.

Google reCAPTCHA
To protect our website forms from spam and automated abuse, we use the reCAPTCHA service provided by Google. This service analyzes behavior to distinguish between humans and bots. Your use of reCAPTCHA is subject to Google’s Privacy Policy and Terms of Service.

Service Providers
We may share your information with trusted third-party service providers who assist us in operating our website, conducting our business, or serving our users (e.g., email delivery services, CRM systems, or hosting providers), so long as those parties agree to keep this information confidential.

4. International Data Transfers
AcroCyte operates globally with offices in Taiwan and the United States. Please be aware that your personal information may be transferred to, stored, and processed in a country other than the one in which you reside. By providing us with your information, you acknowledge and agree to this transfer, storage, or processing. We take all reasonable steps to ensure that your data is treated securely and in accordance with this policy.

5. Data Retention
We retain your personal information only for as long as is necessary to fulfill the purposes for which it was collected, including for the purposes of satisfying any legal, accounting, or reporting requirements. When data is no longer needed, we will securely delete or anonymize it.

6. Access to Your Personal Information & Your Rights
You have the right to request access to, correction of, or deletion of any personal data that we hold about you. Depending on your jurisdiction (such as under the GDPR), you may also have the right to restrict processing, object to processing, or request data portability. To make such a request, please contact our Privacy Team at [info@acrocyte.com].

7. Changes to Our Privacy Policy
We may update this Privacy Policy from time to time to reflect changes in our practices or for other operational, legal, or regulatory reasons. The most current version will always be available on our website. By continuing to access or use our website after those changes become effective, you agree to be bound by the revised Privacy Policy.

Cookie Notice